Notable Labs (NTBL) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends NTBL vs. VINC, RDHL, SNGX, ADXN, MBRX, GLTO, OBSV, ENSC, COEP, and ATHEShould you be buying Notable Labs stock or one of its competitors? The main competitors of Notable Labs include Vincerx Pharma (VINC), RedHill Biopharma (RDHL), Soligenix (SNGX), Addex Therapeutics (ADXN), Moleculin Biotech (MBRX), Galecto (GLTO), ObsEva (OBSV), Ensysce Biosciences (ENSC), Coeptis Therapeutics (COEP), and Alterity Therapeutics (ATHE). These companies are all part of the "pharmaceutical products" industry. Notable Labs vs. Vincerx Pharma RedHill Biopharma Soligenix Addex Therapeutics Moleculin Biotech Galecto ObsEva Ensysce Biosciences Coeptis Therapeutics Alterity Therapeutics Vincerx Pharma (NASDAQ:VINC) and Notable Labs (NASDAQ:NTBL) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, community ranking, profitability, earnings, risk, media sentiment, institutional ownership and valuation. Does the MarketBeat Community prefer VINC or NTBL? Vincerx Pharma received 15 more outperform votes than Notable Labs when rated by MarketBeat users. However, 85.71% of users gave Notable Labs an outperform vote while only 65.63% of users gave Vincerx Pharma an outperform vote. CompanyUnderperformOutperformVincerx PharmaOutperform Votes2165.63% Underperform Votes1134.38% Notable LabsOutperform Votes685.71% Underperform Votes114.29% Is VINC or NTBL more profitable? Notable Labs' return on equity of -80.81% beat Vincerx Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Vincerx PharmaN/A -248.33% -132.73% Notable Labs N/A -80.81%-62.86% Which has more risk & volatility, VINC or NTBL? Vincerx Pharma has a beta of 1.6, indicating that its share price is 60% more volatile than the S&P 500. Comparatively, Notable Labs has a beta of 0.98, indicating that its share price is 2% less volatile than the S&P 500. Do analysts recommend VINC or NTBL? Vincerx Pharma presently has a consensus price target of $2.00, indicating a potential upside of 654.15%. Notable Labs has a consensus price target of $7.00, indicating a potential upside of 0.00%. Given Vincerx Pharma's stronger consensus rating and higher probable upside, equities analysts plainly believe Vincerx Pharma is more favorable than Notable Labs.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vincerx Pharma 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Notable Labs 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media favor VINC or NTBL? In the previous week, Vincerx Pharma had 4 more articles in the media than Notable Labs. MarketBeat recorded 4 mentions for Vincerx Pharma and 0 mentions for Notable Labs. Notable Labs' average media sentiment score of 0.00 beat Vincerx Pharma's score of -0.09 indicating that Notable Labs is being referred to more favorably in the news media. Company Overall Sentiment Vincerx Pharma Neutral Notable Labs Neutral Do insiders and institutionals hold more shares of VINC or NTBL? 44.0% of Vincerx Pharma shares are held by institutional investors. Comparatively, 70.5% of Notable Labs shares are held by institutional investors. 17.2% of Vincerx Pharma shares are held by insiders. Comparatively, 1.2% of Notable Labs shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has preferable earnings & valuation, VINC or NTBL? Notable Labs has higher revenue and earnings than Vincerx Pharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVincerx PharmaN/AN/A-$40.16M-$1.03-0.26Notable Labs$313K0.00-$11.26MN/AN/A SummaryVincerx Pharma and Notable Labs tied by winning 7 of the 14 factors compared between the two stocks. Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Get Notable Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for NTBL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NTBL vs. The Competition Export to ExcelMetricNotable LabsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.24M$6.53B$5.10B$8.84BDividend YieldN/A8.11%5.04%4.07%P/E RatioN/A5.5095.1214.22Price / SalesN/A375.021,217.3088.42Price / CashN/A52.5939.4936.27Price / BookN/A10.276.976.37Net Income-$11.26M$153.22M$118.73M$225.56M Notable Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NTBLNotable LabsN/AN/A$7.00+∞-92.7%$2.24M$313,000.000.0040Gap DownHigh Trading VolumeVINCVincerx Pharma2.9731 of 5 stars$0.27-3.8%$2.00+654.1%-60.6%$8.90MN/A0.0060RDHLRedHill Biopharma0.9881 of 5 stars$6.79+6.1%N/A-96.9%$8.69M$6.53M0.00210News CoverageSNGXSoligenix0.9628 of 5 stars$3.46-1.4%N/A-49.0%$8.69M$840,000.000.0020ADXNAddex Therapeutics2.6699 of 5 stars$8.13+10.2%$30.00+269.0%+23.6%$8.62M$1.83M0.0030Gap UpMBRXMoleculin Biotech3.0386 of 5 stars$2.67flat$31.00+1,061.0%-67.1%$8.01MN/A0.0020Analyst ForecastAnalyst RevisionGLTOGalecto3.1146 of 5 stars$6.02+3.6%$10.00+66.1%-60.6%$7.95MN/A0.0040OBSVObsEvaN/AN/AN/AN/A$7.94M$20.11M-0.1150ENSCEnsysce Biosciences0.2194 of 5 stars$0.57-13.1%N/A-27.1%$7.91M$2.23M0.0010Gap DownCOEPCoeptis TherapeuticsN/A$0.19-0.9%N/A-83.3%$7.90M$80,000.000.002ATHEAlterity Therapeutics3.1517 of 5 stars$1.08+2.9%$4.00+270.4%N/A$7.88MN/A0.0010Gap Up Related Companies and Tools Related Companies Vincerx Pharma Alternatives RedHill Biopharma Alternatives Soligenix Alternatives Addex Therapeutics Alternatives Moleculin Biotech Alternatives Galecto Alternatives ObsEva Alternatives Ensysce Biosciences Alternatives Coeptis Therapeutics Alternatives Alterity Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NTBL) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Notable Labs, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Notable Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
